Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas.
Chantana PolprasertYasuhide TakeuchiHideki MakishimaKitsada WudhikarnNobuyuki KakiuchiNichthida TangnuntachaiThamathorn AssanasenWimonmas SitthiHamidah MuhamadPanisinee LawasutSunisa KongkiatkamonUdomsak BunworasateKoji IzutsuYuichi ShiraishiKenichi ChibaHiroko TanakaSatoru MiyanoSeishi OgawaKenichi YoshidaPonlapat RojnuckarinPublished in: Leukemia & lymphoma (2020)
Extranodal NK/T cell lymphomas (ENKTCLs) are aggressive Epstein-Barr virus-associated T/NK neoplasms that predominantly affect Asians. To explore the causative somatic events, we conducted a comprehensive genetic analysis of 19 ENKTCL patients by whole-genome (N = 2), whole-exome (N = 16), and targeted sequencing (N = 15). Commonly deregulated gene pathways in ENKTCLs included epigenetic modifiers (58%, 11/19) followed by human leukocyte antigens (HLAs) and related genes including HLA-A, B2M, TAP1, CD274, and PDCD1LG2 (32%, 6/19), and JAK-STAT pathway (26%, 5/19). Conspicuously, loss-of-function mutations in HLA-A were recurrently identified in ENKTCLs (16%, 3/19). HLA protein expression was examined by immunohistochemistry in 16 patients and lower expression was associated with advanced stages at presentation (p = .007). In conclusion, the defective antigen presenting pathway is common and related to disease progression, suggesting immune escape as a pathogenic mechanism of ENKTCLs.